Microsoft Word - SET-AIS-CP 007-2020 Acquisition of spectrum license.docx (Translation) AIS-CP 007/2020 19 February 2020 Subject: Acquisition of spectrum license To: President The Stock Exchange of
Assets by Subsidiary of DOD Biotech Public Company Limited for the Purchase and Acceptance of Transfer of the Entire Business of BGP Spectrum Power Co., Ltd., and Establishment of Subsidiary, Classified as
continued to expand and improve network quality with new 2600MHz spectrum and enhance 4G/5G network capacity to secure leading position. As a result, EBITDA (Pre-TFRS16) decreased -3.0%YoY, in line with FY20
. As a result, EBITDA in 1H21 increased by 1.1%YoY despite soften core service revenue, offset by cost control in SG&A. With the 700MHz spectrum license and 26GHz spectrum license acquired in 1H21, D&A
Bt6,311mn, -5.0% YoY and -8.1% QoQ. Excluding unrealized FX loss, normalized NPAT was 6,345mn, -7.0% YoY due to higher spectrum amortization and -5.8% QoQ from lower core service revenue. The full- year
was Bt6,644mn, decreasing -1.7%YoY as D&A rose from new spectrum and expansion and decreasing -7.3%QoQ from unrealized foreign exchange loss and tax benefit in 4Q20. Market and Competitive Environment
, and minimum payment on TOT’s 2100MHz spectrum. In this MDA material, we present a financial income statement based on pre-TFRS for comparison with FY19. 2. In 4Q20, according to the Royal Decree No. 695
) was Bt7,004mn -7.5% YoY and -0.9% QoQ. 2020 Outlook In February, AIS won the bid of spectrum band for 5G development to secure long term leadership and to build new revenue stream in the future as well